Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients
Launched by RIJNSTATE HOSPITAL · Jan 19, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether having discussions with a multidisciplinary team (MDT) before surgery can help high-risk patients who are undergoing noncardiac surgery. The goal is to see if these team meetings can reduce serious complications after surgery compared to the usual care patients receive. Additionally, the trial will explore if these discussions can improve patients' overall health, quality of life, and even save costs related to their care.
To participate, patients must be 18 years or older, have a higher risk for complications (as determined by specific health assessments), and be scheduled for elective or semi-elective noncardiac surgery. Participants will fill out questionnaires at various points after their surgery to track their recovery and wellbeing. It's important to note that this study is taking place in hospitals that do not currently have structured preoperative MDT meetings in place.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older; and
- • American Society of Anesthesiology Physical Status (ASA-PS) score is 3 or more; and
- • Clinical Frailty Scale score is 4 or more; and
- • Patient is planned for elective or semi-elective noncardiac surgery; and
- * As stated by the Dutch perioperative guideline:
- • Doubt by the surgeon or anesthesiologist (or other discipline) regarding harm-benefit ratio of the surgical procedure; or
- • Doubt if the correct measures were taken to limit the perioperative risk as much as possible; or
- • Doubt if the patient agrees with the surgery or the anesthesiologic treatment and expected risks.
- Exclusion Criteria:
- • no informed consent
- • unable to communicate with patient (either directly or through third party)
- • emergency surgery
- • Proposed surgical intervention for which a structured preoperative multidisciplinary team meeting, similar to the current study intervention, already exists in this respective hospital at the start of the study
About Rijnstate Hospital
Rijnstate Hospital is a leading healthcare institution based in the Netherlands, dedicated to providing high-quality patient care and advancing medical research. With a strong emphasis on innovation and collaboration, Rijnstate Hospital actively engages in clinical trials to explore new treatment options and improve patient outcomes across various medical fields. The hospital's multidisciplinary approach integrates the expertise of healthcare professionals, researchers, and academic partners, ensuring rigorous scientific methodologies and adherence to ethical standards. Committed to enhancing the health and well-being of the communities it serves, Rijnstate Hospital plays a pivotal role in the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Apeldoorn, , Netherlands
Gouda, , Netherlands
Zaandam, , Netherlands
Heerlen, , Netherlands
Maastricht, , Netherlands
'S Hertogenbosch, , Netherlands
Amersfoort, , Netherlands
Amsterdam, , Netherlands
Dordrecht, , Netherlands
Nijmegen, , Netherlands
Roosendaal, , Netherlands
Rotterdam, , Netherlands
Veldhoven, , Netherlands
Patients applied
Trial Officials
Nick J. Koning, MD PhD DESA
Principal Investigator
Rijnstate Hospital
Jacqueline E. Vernooij, MD, MA
Study Director
Rijnstate Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials